References
- Martin SD, Coukos G, Holt RA, Nelson BH: Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era. Ann Oncol. 2015; 12: 2357-2374
- Apetoh L, Ladiore S, Coukos G, Ghiringhelli F. Combining immunotherapy and anticancer agents: the right path to achieve cancer cure? Ann Oncol. 2015; 9: 1813-1823
- Lanitis E, Irving M, Coukos G. Targeting the tumor vasculature to enhance T cell activity. Curr Opin Immunol. 2015; 33: 53-63
- Chiang CL, Bajint K, Coukos G, Kandalaft LE. Potential approaches for more successful dendritic cell-based immunotherapy. Expert Opin Ther. 2015; 15: 569-582
- Michot JM, Bigenwald C, Champiat S, Collins M, Carbonnel F, Postel-Vinay S, et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer. 2016; 54: 139-148